Literature DB >> 21604063

Renal function assessment in patients with systemic lupus erythematosus.

Marco Ulises Martínez-Martínez1, Jaime Antonio Borjas-García, Martín Magaña-Aquino, Enrique Cuevas-Orta, Lilia Llamazares-Azuara, Carlos Abud-Mendoza.   

Abstract

Few studies have evaluated the glomerular filtration rate (GFR) in patients with systemic lupus erythematosus (SLE). Even though the National Kidney Foundation (NKF) suggests using the equations to estimate GFR, rheumatologists continue using creatinine clearance (CCl). The main objective of our study was the assessment of different equations to estimate GFR in patients with SLE: Simplified MDRD study equation (sMDRD), CCl, Cockcroft Gault (CG), CG calculated with ideal weight (CGi), Mayo Clinic Quadratic (MCQ), and Chronic Kidney Disease Epidemiology Collaboration Equation (CKD-EPI). CKD-EPI was considered as the reference standard, and it was compared with the other equations to evaluate bias, correlation (r), sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), percentage of measurement of GFR between 70-130% of GFR measured through CKD-EPI (P30) and to compute the ROC curves. Adequacy of the 24-h urine collection was evaluated. To classify patients into GFR < 60 ml/min/1.73 m(2), the best sensitivity and NVP were obtained with sMDRD: the best PPV and specificity with MCQ. P30 was 99.3% with sMDRD, 77.5% CCl, 91.7% CG, 96.7% CGi, and 77.2% with MCQ. The lowest bias was for sMDRD and the highest for CCl. Only 159 (52.6%) urine collections were considered adequate, and when these patients were re-evaluated, the statistical results improved for CCl. CGi was better in general than CG. CCl should not be considered as an adequate GFR estimation. Ideal weight is better than real weight to calculate GFR through CG in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21604063     DOI: 10.1007/s00296-011-1940-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  31 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  Measurement of renal function in chronic renal disease.

Authors:  A S Levey
Journal:  Kidney Int       Date:  1990-07       Impact factor: 10.612

3.  Estimating renal function in lupus nephritis: comparison of the Modification of Diet in Renal Disease and Cockcroft Gault equations.

Authors:  N Kasitanon; D M Fine; M Haas; L S Magder; M Petri
Journal:  Lupus       Date:  2007       Impact factor: 2.911

4.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

5.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function.

Authors:  Marc Froissart; Jerome Rossert; Christian Jacquot; Michel Paillard; Pascal Houillier
Journal:  J Am Soc Nephrol       Date:  2005-01-19       Impact factor: 10.121

7.  Estimation of glomerular filtration rate in patients with systemic lupus erythematosus.

Authors:  Y Y Leung; K M Lo; L S Tam; C C Szeto; E K Li; E W Kun
Journal:  Lupus       Date:  2006       Impact factor: 2.911

8.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

9.  European consensus statement on the terminology used in the management of lupus glomerulonephritis.

Authors:  C Gordon; D Jayne; C Pusey; D Adu; Z Amoura; M Aringer; J Ballerin; R Cervera; J Calvo-Alén; C Chizzolini; Jm Dayer; A Doria; F Ferrario; J Floege; L Guillevin; M Haubitz; F Hiepe; F Houssiau; P Lesavre; L Lightstone; Pl Meroni; O Meyer; B Moulin; K O'Reilly; M Praga; H Schulze-Koops; Ra Sinico; Kgc Smith; A Tincani; C Vasconcelos; G Hughes
Journal:  Lupus       Date:  2009-03       Impact factor: 2.911

10.  Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis.

Authors:  Siu-Ka Mak; Kin-Yee Lo; Man-Wai Lo; Shuk-Fan Chan; Gensy M W Tong; Ping-Nam Wong; Andrew K M Wong
Journal:  Nephrology (Carlton)       Date:  2008-06       Impact factor: 2.506

View more
  1 in total

1.  Is serum uric acid a predictor of long-term renal outcome in lupus nephritis?

Authors:  Michelle Remião Ugolini-Lopes; Samara S Gavinier; Elaine Leon; Vilma Trindade Viana; Eduardo Ferreira Borba; Eloisa Bonfá
Journal:  Clin Rheumatol       Date:  2019-06-02       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.